Why is Saroja Pharma In falling/rising?

As of 15-Sep, Saroja Pharma Industries India Ltd's stock price is flat at 47.05, with no change (0.00%). The stock has underperformed in the short term, with a 1-week return of -4.47%, while the Sensex has gained 1.20%. Over the past month, however, the stock has shown a positive return of 20.64%, significantly outperforming the Sensex's 1.78%. Despite this recent uptick, the stock's year-to-date performance is concerning, down 21.58%, and it has also declined 26.25% over the past year. Today's price summary indicates that the stock has outperformed its sector by 0.45%, but there is a notable decline in investor participation, with delivery volume dropping by 50% compared to the 5-day average. The stock is currently trading above its 50-day, 100-day, and 200-day moving averages, but below its 5-day and 20-day moving averages, suggesting mixed signals in its recent performance.
In the broader market context, Saroja Pharma's short-term performance contrasts sharply with the benchmark, as it has experienced a decline while the Sensex has risen. This divergence highlights the stock's volatility and potential investor concerns. The liquidity of the stock appears adequate for trading, as it represents 2% of the 5-day average traded value. However, the significant drop in delivery volume could indicate waning interest from investors, which may contribute to the stock's flat price movement. Overall, while the stock has shown some positive momentum recently, the broader trends and declining participation suggest caution among investors.